NT
Nektar Therapeutics
🇬🇧XLON.0UNLUnited KingdomHealthcare
$67.08USDup +0.69 (+1.04%)ClosedEnd of day9:49 PM
Price$67.08+0.69 (+1.04%)
Profile
- Healthcare
- Biotechnology
- United Kingdom
Identity
- Exchange
- London Stock Exchange . XLON
- Type
- Stock
- ISIN
- US6402683063
- CUSIP
- Not reported
Company
- Employees
- 63
- Headquarters
- San Francisco, United States
- Website
- https://www.nektar.com
- CEO
- Mr. Howard W. Robin
Market
- Shares outstanding
- 173.1M
- Market cap
- $11.61B
Highlights
- Market cap
- $11.49B
- EPS LTM
- -$0.91calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -73.89calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $54.59M-27.15%down year on year
- Net income
- -$157.13M-28.51%down year on year
- Gross margin
- 99.36%+20.32%up year on year
- Free cash flow
- -$234.05M-25.78%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.